1999
DOI: 10.1016/s0378-4347(99)00108-5
|View full text |Cite
|
Sign up to set email alerts
|

Determination of fenoprofen in serum by capillary isotachophoresis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2000
2000
2010
2010

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 25 publications
0
4
0
Order By: Relevance
“…Sádecká et al [37] applied cITP to determine concentration of fenoprofen and obtained mean recovery between 89.5 and 95.2%, whereas the within-day S.D. and between-day S.D.…”
Section: Resultsmentioning
confidence: 99%
“…Sádecká et al [37] applied cITP to determine concentration of fenoprofen and obtained mean recovery between 89.5 and 95.2%, whereas the within-day S.D. and between-day S.D.…”
Section: Resultsmentioning
confidence: 99%
“…The above approach has been used for the achiral analysis of fenoprofen, naproxen, ibuprofen, and ketoprofen in human serum, with minimal sample pretreatment prior to analysis [150][151][152], and applied to the enantiomeric resolution of fenoprofen, flurbiprofen, ibuprofen, and ketoprofen using TM-b-CD as a chiral selector [153]. Following a series of preliminary investigations involving variation of the leading and terminating electrolyte composition, enantiomeric resolution of the four analytes was achieved using a lead electrolyte consisting of HCl (10 mM) containing methylhydroxyethylcellulose (0.2% w/v), adjusted to pH 4.5 by the addition of 6-aminocaproic acid, containing TM-b-CD (10 mM) and a terminating electrolyte of MES (5 mM) adjusted to pH 7.0 with Tris.…”
Section: Isotachophoretic Enantiomeric Analysis Of 2-apasmentioning
confidence: 99%
“…A large number of CE-based drug assays have been described, including those for butalbital in serum [69], carbamazepine and carbamazepine-10,11-epoxide in plasma and serum by MEKC in an electroosmosis-free environment [70], albendazole, albendazole sulfoxide and albendazole sulfone in plasma using NACE [71], valproic acid in serum using CZE with indirect LIF detection [72], the two diastereomers quinidine and quinine in plasma, urine and saliva using MEKC, CZE and CE-based immunoassays with LIF detection [73], phenprocoumon in plasma and urine using at-line solid-phase extraction CE [74], 5-fluorouracil and 5-fluoro-2'-deoxyuridine-5'-monophosphate in pancreatic cancer cell line and other biological materials [75], etoposide and etoposide phosphate in plasma employing CE with native, wavelength-resolved LIF detection [76], tramadol in urine by CE with native, wavelengthresolved LIF and without sample pretreatment [77], cefpirome by MEKC in microdialysis and plasma obtained in vivo from human volunteers [78], digoxin and gentamicin in serum employing CE-based immunoassays [79], five sulfonylurea drugs (chlorpropamide, tolbutamide, glipizide, gliclazide and glibenclamide) in serum by MEKC [80], the nonionic contrast agent iohexol in serum [81], daunorubicine in biopsy samples from Kaposi sarcoma tumors and plasma using CE-LIF [82], (E)-5-(2-bromovinyl)-2'-deoxyuridine in plasma [83] and plasma and urine [84], and fenoprofen in serum by capillary isotachophoresis [85]. Furthermore, a CZE assay for quantitation of human immunodeficiency virus-1 protease inhibitors (crixivan, virasept, invirase, fortovase and norvir) in human serum was developed by Chelyapov et al [86].…”
Section: Drugs In Biofluids and Tissuesmentioning
confidence: 99%